TR201911128T4 - Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. - Google Patents
Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. Download PDFInfo
- Publication number
- TR201911128T4 TR201911128T4 TR2019/11128T TR201911128T TR201911128T4 TR 201911128 T4 TR201911128 T4 TR 201911128T4 TR 2019/11128 T TR2019/11128 T TR 2019/11128T TR 201911128 T TR201911128 T TR 201911128T TR 201911128 T4 TR201911128 T4 TR 201911128T4
- Authority
- TR
- Turkey
- Prior art keywords
- fhbp
- nessseria
- menuinulludis
- vaccination
- relates
- Prior art date
Links
- 238000002255 vaccination Methods 0.000 title 1
- 101710186862 Factor H binding protein Proteins 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Buluş, bir yabani tür V2 fHbp üzerinden artmış stabiliteye sahip bir modifiye edilmiş V2 fHbp; SEKANS KİMLİK NUMARASI: 1'in sekansına en az %85 özdeşliğe sahip bir amino asit sekansına sahip bir modifiye edilmiş V2 fHbp ile ilgilidir, burada hem Ser137 hem de Gly138 mutasyona uğramaktadır veya hem Val112 hem de Leu114 mutasyona uğramaktadır; ayrıca buluş immünojenik, farmasötik ve aşı bileşimleri; nükleik asit ve bir konak hücre ve bu tür bileşimlerin kullanım yöntemleri ile ilgilidir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1215005.8A GB201215005D0 (en) | 2012-08-23 | 2012-08-23 | Stabilised meningitis vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201911128T4 true TR201911128T4 (tr) | 2019-08-21 |
Family
ID=47045261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/11128T TR201911128T4 (tr) | 2012-08-23 | 2013-08-22 | Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9629905B2 (tr) |
| EP (1) | EP2887956B1 (tr) |
| AU (1) | AU2013304832B2 (tr) |
| CY (1) | CY1126292T1 (tr) |
| DK (1) | DK2887956T3 (tr) |
| ES (1) | ES2739616T3 (tr) |
| GB (1) | GB201215005D0 (tr) |
| HU (1) | HUE044495T2 (tr) |
| LT (1) | LT2887956T (tr) |
| PL (1) | PL2887956T3 (tr) |
| PT (1) | PT2887956T (tr) |
| SI (1) | SI2887956T1 (tr) |
| TR (1) | TR201911128T4 (tr) |
| WO (1) | WO2014030003A1 (tr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE052293T2 (hu) * | 2014-02-28 | 2021-04-28 | Glaxosmithkline Biologicals Sa | Módosított fHbp meningococcus-polipeptidek |
| BE1022641B1 (fr) * | 2014-07-17 | 2016-06-23 | Glaxosmithkline Biologicals Sa | POLYPEPTIDES MENINGOCOCCIQUES fHbp MODIFIES |
| SG11201610946YA (en) | 2014-07-17 | 2017-01-27 | Glaxosmithkline Biolog Sa | Meningococcus vaccines |
| BR112017001417B1 (pt) | 2014-07-23 | 2023-11-07 | Children's Hospital & Research Center At Oakland | Variantes da proteína de ligação ao fator h (fhbp), composição imunogênica e uso de uma fhbp variante referência cruzada |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ555937A (en) * | 2005-01-27 | 2009-05-31 | Childrens Hosp & Res Ct Oak | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| WO2009114485A2 (en) | 2008-03-10 | 2009-09-17 | Children's Hospital & Research Center At Oakland | Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use |
-
2012
- 2012-08-23 GB GBGB1215005.8A patent/GB201215005D0/en not_active Ceased
-
2013
- 2013-08-22 PT PT13765388T patent/PT2887956T/pt unknown
- 2013-08-22 AU AU2013304832A patent/AU2013304832B2/en active Active
- 2013-08-22 EP EP13765388.7A patent/EP2887956B1/en active Active
- 2013-08-22 SI SI201331531T patent/SI2887956T1/sl unknown
- 2013-08-22 WO PCT/GB2013/052215 patent/WO2014030003A1/en active Application Filing
- 2013-08-22 US US14/423,047 patent/US9629905B2/en active Active
- 2013-08-22 DK DK13765388.7T patent/DK2887956T3/da active
- 2013-08-22 HU HUE13765388 patent/HUE044495T2/hu unknown
- 2013-08-22 ES ES13765388T patent/ES2739616T3/es active Active
- 2013-08-22 TR TR2019/11128T patent/TR201911128T4/tr unknown
- 2013-08-22 PL PL13765388T patent/PL2887956T3/pl unknown
- 2013-08-22 LT LTEP13765388.7T patent/LT2887956T/lt unknown
-
2019
- 2019-07-25 CY CY20191100791T patent/CY1126292T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014030003A1 (en) | 2014-02-27 |
| AU2013304832A1 (en) | 2015-03-05 |
| ES2739616T3 (es) | 2020-02-03 |
| LT2887956T (lt) | 2019-08-12 |
| CY1126292T1 (el) | 2024-02-16 |
| EP2887956B1 (en) | 2019-07-03 |
| PL2887956T3 (pl) | 2019-10-31 |
| PT2887956T (pt) | 2019-08-07 |
| US9629905B2 (en) | 2017-04-25 |
| HUE044495T2 (hu) | 2019-10-28 |
| EP2887956A1 (en) | 2015-07-01 |
| US20150190494A1 (en) | 2015-07-09 |
| GB201215005D0 (en) | 2012-10-10 |
| SI2887956T1 (sl) | 2019-09-30 |
| AU2013304832B2 (en) | 2017-07-20 |
| DK2887956T3 (da) | 2019-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1126292T1 (el) | Παραλλαγμα της fhbp του neisseria meningitidis και χρηση του για εμβολιασμο | |
| NZ702145A (en) | Bluetongue virus recombinant vaccines and uses thereof | |
| EA201391240A1 (ru) | Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza | |
| TR201820102T4 (tr) | Fabri hastalığı gen tedavisi. | |
| EP3563865A3 (en) | Prostate-associated antigens and vaccine-based immunotherapy regimens | |
| CY1120772T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ | |
| BR112014019901A8 (pt) | Proteínas de fator viii recombinante | |
| BR112013003825A2 (pt) | conjugados, partículas, composições e métodos relacionados | |
| BR112018017307A2 (pt) | molécula de ácido nucleico isolada, composição, e, métodos para indução de uma resposta imune contra um zika vírus, para tratamento de um indivíduo e para prevenção de uma infecção por zika vírus | |
| MA37749B1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
| EA201692359A1 (ru) | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса | |
| EA201891460A1 (ru) | Композиция дендритных клеток | |
| MX358711B (es) | Inmunogenos para vacunacion contra vih. | |
| BR112014011560A2 (pt) | complexos imunogênicos de carbômeros polianiônicos e polipeptídeos env, e métodos de fabricação e uso dos mesmos | |
| EA201500054A1 (ru) | Аттенуированные вакцины против streptococcus suis и способы их получения и применения | |
| EA201491643A1 (ru) | Идентификация мутаций канал-опсина-2 (chop2) и способы применения | |
| CY1123403T1 (el) | Τροποποιημενα κυτταρα ξενιστες και χρησεις αυτων | |
| EA201590794A1 (ru) | Рекомбинантные нейротоксины clostridium botulinum | |
| BR112013030396A2 (pt) | polipeptídeo, polinucleotídeo, vetor, célula hospedeira, composição imunogênica, vacina, e, uso de uma composição imunogênica ou de uma vacina | |
| BR112015000585A2 (pt) | cepas mutantes de mycoplasma hyopneumoniae | |
| PH12015502353A1 (en) | Fusion polypeptides and vaccines | |
| CY1124110T1 (el) | Συνθεσεις και μεθοδοι μεταλλαγμενου παραγοντα viii | |
| WO2013177593A3 (en) | Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies | |
| AR128395A2 (es) | Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9 | |
| IN2014DN09963A (tr) |